Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment

Anne Blaes, Daniel Duprez, Todd Defor, Ryan Shanley, Heather Beckwith, Tufia Haddad, David Potter, Douglas Yee, Kinjal Sanghavi, Pamala Jacobson

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences